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1. Introduction
The misfolding and aggregation of specific proteins have been
recognized as the cause of widespread degenerative patholo-
gies such as Alzheimer’s and Parkinson’s diseases.[1] In the spe-
cific case of Alzheimer’s disease (AD), the neuronal and synap-
tic loss has been commonly identified with the presence of
senile plaques of extracellular highly fibrillogenic amyloid-beta
peptides (Ab). Ab peptides, the longest one being Ab(1-42),
are produced as soluble monomers. The prevailing hypothesis
is that cell toxicity, associated with neuronal death, is triggered
by intermediate soluble oligomeric forms of Ab peptide devel-
oping at a very early stage of aggregation, rather than by the
final insoluble plaques composed of Ab fibrils.[2]
Ab aggregation is thought to proceed through the nuclea-
tion–polymerization model.[3] This model consists of an initial
rate-limiting nuclei formation, described as “lag phase”, corre-
sponding to the formation of toxic oligomeric species at the
early stages of Ab aggregation, followed by an elongation/
polymerization phase which leads to the formation of fibrils.
One of the major challenges for AD research is to detect the
early events of aggregation since the classical detection meth-
ods, such as Congo Red and thioflavin T staining, transmission
electron microscopy (TEM), X-ray diffraction and classical NMR
are all too insensitive to detect the minute soluble species
formed during the lag phase.[4] Prompt and sensitive detection
would also be crucial to allow AD early diagnosis and design
of powerful therapeutic treatments.
In this work, we exploit the unique properties of an optical
label-free refractometric sensing platform to propose a novel
approach for investigating the initial lag-phase of Ab(1-42) ag-
gregation. Our sensing approach allows the real-time optical
detection of local refraction index changes occurring as aggre-
gation takes place. The method is based on the optical inter-
rogation of a dielectric multilayer (one-dimensional photonic
We propose the application of a new label-free optical tech-
nique based on photonic nanostructures to real-time monitor
the amyloid-beta 1-42 (Ab(1-42)) fibrillization, including the
early stages of the aggregation process, which are related to
the onset of the Alzheimer’s Disease (AD). The aggregation of
Ab peptides into amyloid fibrils has commonly been associated
with neuronal death, which culminates in the clinical features
of the incurable degenerative AD. Recent studies revealed that
cell toxicity is determined by the formation of soluble oligo-
meric forms of Ab peptides in the early stages of aggregation.
At this phase, classical amyloid detection techniques lack in
sensitivity. Upon a chemical passivation of the sensing surface
by means of polyethylene glycol, the proposed approach
allows an accurate, real-time monitoring of the refractive index
variation of the solution, wherein Ab(1-42) peptides are aggre-
gating. This measurement is directly related to the aggregation
state of the peptide throughout oligomerization and subse-
quent fibrillization. Our findings open new perspectives in the
understanding of the dynamics of amyloid formation, and vali-
date this approach as a new and powerful method to screen
aggregation at early stages.
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crystal) sustaining an electromagnetic surface wave.[5] The
sensing technique is reminiscent of surface plasmon resonance
(SPR). Instead of having a surface plasmon propagating on
a thin metallic film, an evanescent wave called “Bloch surface
wave” (BSW) is coupled on a purely dielectric multilayer struc-
ture.[6] Depending on the materials used and the layout of the
periodic dielectric multilayer, the BSW can be produced in
a wide spectral range, from the visible to the near-infrared.[7]
This spectral tunability represents one of the main advantages
of BSW-based optical transduction systems, as compared to
SPR. In addition, BSWs present very narrow resonances that
can increase the resolution and improve the limit of detection
in label-free detection schemes. BSWs generated on dielectric
multilayers are sensitive to external perturbations of the refrac-
tive index close to the surface of the photonic multilayer.[8]
In the following, we report on a proof of principle of the
BSW-based detection technique for sensing protein aggrega-
tion by monitoring in real time the refractive index variation
(Dn) of an aqueous solution containing the Ab(1-42) peptide
during early aggregation and fibril formation. The multilayer
surface is directly contacted with the probed aqueous medium
and the sensing chamber is positioned vertically (see Experi-
mental section). Hence, the measurements using BSWs monitor
a local variation of the refractive index of the solution, which is
directly related to the depletion of the concentration of the
Ab(1-42) monomeric form during aggregation.
2. Results and Discussion
2.1. Ab(1–42) Aggregation Sensing with Bare Multilayer Sur-
face
The monomeric Ab(1-42) peptide was incubated at 37 8C in the
fluidic chamber in the presence of an initial bare (non-func-
tionalized) multilayer. (For details on sample preparation and
experimental setup see the Experimental Section.) The mea-
surement consisted in time-monitoring the angular position of
a BSW resonance dip upon laser illumination through a prism.
A representative aggregation curve obtained during incuba-
tion of the Ab(1-42) peptide is shown in Figure 1A. The varia-
tion in the refractive index Dn of the initially monomeric Ab(1-
42) solution is monitored as a function of time by taking the
BSW resonance position on a linear CMOS camera. We ob-
served a sudden increase of the signal followed by a slow ex-
ponential decay of Dn of the solution within the time frame
where other techniques show a lag time.[3c] The Dn decrease is
in accordance with the Ab(1-42) monomer depletion due to
aggregation. The BSW-assisted monitoring was compared with
TEM imaging data to allow the detection of the Ab(1-42) spe-
cies and their corresponding morphologies before and during
aggregation.[9] TEM imaging was performed on the sample
probed at different stages of aggregation, thus revealing the
morphological evolution of the peptide from a monomeric
(Figure 1B, micrograph a), to an oligomeric and pre-fibrillar
stage (Figure 1B, micrographs b–d), and to a non-soluble ag-
gregate fibrillar conformation (Figure 1B, micrographs e and f).
Many different models of the aggregation process have
been proposed, but to the best of our knowledge there is no
direct experimental evidence that allows assessment of the
events that we report shortly after the monomer injection. A
simple empirical model describing the variation of Dn as
sensed by the BSW involves the contribution from two terms,
shown in Equation (1):
Dn ¼ Dns þ Dnb ð1Þ
wherein Dns is the refractive index variation due to surface ad-
sorption/desorption processes, and Dnb is the refractive index
variation occurring in the bulk solution, as observed within the
evanescent tail of BSWs. Since our multilayer presents a bare
silicon oxinitride surface, Dns is mainly due to the hydrophobic
adsorption of the Ab(1-42) peptide onto the surface. Instead,
Figure 1. A) Refractive index variation Dn, in pixel shift, of an Ab(1-42) monomer peptide solution incubated at 37 8C at the initial concentration of 17,3 mm in
10 mm Tris HCl, pH 7.4. Roman numbers refer to the three distinct zones of the Dn monitoring, as described in the text. The lower-case letters refer to the
TEM micrographs collected at different stages of aggregation, during the Dn monitoring. B) TEM micrographs of Ab(1-42) monomer at the initial concentra-
tion of 17 mm (in 10 mm Tris HCl, pH 7.4) at : a) t=0, T=4 8C; b) t=30 min, T=37 8C; c) t=2 h, T=37 8C; d) t=10 h, T=37 8C; e) t=24 h, T=37 8C; f) t=48 h,
T=37 8C. The morphological changes in the peptide solutions during incubation are displayed.
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Dnb refers mainly to the variation of the Ab(1-42) monomer
concentration in the bulk solution. The decrease of the mono-
mer concentration reveals the formation of non-soluble aggre-
gates. The final result of the Ab(1-42) aggregation process, the
precipitate of the non-soluble fibers, statistically accumulates
at the bottom of the vertically positioned sensing chamber,
away from the BSW probe.
The overall time evolution of the refractive index value Dn,
as shown in Figure 1A, can be divided into three distinct
stages (labeled with Roman numbers in Figure 1A) that are
discussed in the following:
I) An initial period characterized by a steep increase of Dn
during the first approximately 2 h of the experiment. This
is consistent with the adsorption or physisorption of the
Ab(1-42) peptide in an adhesion-competent conforma-
tion, onto the silicon oxinitride surface. This event produ-
ces a local increase of Dns. This surface-loading mecha-
nism hampers the direct observation of the Dnb decrease
due to peptide aggregation in this very early stage. Nev-
ertheless, at this specific early stage, the changes of the
concentrations in the bulk solution are expected to be
negligible.
II) A maximum amplitude of the curve, attained at ~2 h and
characterized by the amount of the overall Dn change as
measured from the start of the experiment. The reaching
of the maximum refractive index value can be associated
to an equilibrium condition due, for example, to the satu-
ration of the surface and a decreased availability of free
adhesion-competent peptides because of a simultaneous
polymerization occurring in the solution.
III) A slow and steady decrease of Dn as observed after pass-
ing the maximum. The exponential decrease of the refrac-
tive index can be possibly ascribed to two processes: the
detachment of the peptide from the surface, and/or the
formation of fibrillar structures according to the aggrega-
tion mechanism, and thereby depleting the bulk solution.
Both of them lead to a decrease of Dn. In the following
we will show that different conformational species of
Ab(1-42) exhibit different affinities for the surface.
2.2. Ab(1–42) Aggregation Sensing with PEG-ylated Multi-
layer Surface
For a better understanding of the type of process observed
during phase III in Figure 1A, we explored an alternative ap-
proach based on a chemical coating of the multilayer. It has
been shown[10] that polyethylene glycol (PEG) of a molecular
weight of 750 Da, when attached to a glass-like surface, forms
a brush-like self-assembled monolayer (SAM). The SAM thick-
ness is reported to be 50–70 . The chemical modification of
the multilayer surface by means of PEG was performed to
obtain an almost inert surface.[11] In this case, the modified
multilayer surface should therefore sense the process of Ab(1-
42) aggregation with a less significant influence of the peptide
interactions with the surface.
The monitoring of Ab(1-42) monomer aggregation with
a PEG-ylated multilayer is shown in Figure 2A, where it is re-
ferred to as MPEG. The MPEG curve reveals an initial positive pixel
shift that is four times smaller as compared to the case of the
same experiment with a bare multilayer, referred to as MBARE in
Figure 2A. In fact, on the PEG-ylated multilayer surface a small-
er amount of adhesion-competent peptide is adsorbed, caus-
ing a smaller Dns increase. After 10 h of incubation, this curve
reaches negative values for the BSW resonance shift. This
means that the refractive index of the solution, as sensed by
the BSW, at this stage has become lower compared to the
value measured at the initial stage of the incubation. This does
not happen when incubating the Ab(1-42) monomer with
Figure 2. A) Real-time refractive index variation of Ab(1-42) peptides, incu-
bated at 37 8C, at different initial aggregation states and experimental condi-
tions: MBARE, 17.3 mm initially monomeric peptide in contact with a bare mul-
tilayer, MPEG, 17.3 mm initially monomeric peptide in contact with a PEG-
ylated multilayer, PFBARE, 59 mm protofibril in contact with a bare multilayer,
and FBARE, fibril form of the peptide (produced incubating a 15 mm monomer-
ic sample at 37 8C for 48 h) in contact with a bare multilayer. B) TEM micro-
graphs of: protofibril at the initial concentration of 59 mm at: a and
a1) t=0 h, T=4 8C; b and b1) t=24 h, T=37 8C; fibril at : c) t=0 h, T=4 8C.
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a bare surface because of the shielding due to the initial mass-
loading mechanism. Therefore, the presence of a PEG coating
effectively decreased the loading effect, thus making the BSW
mainly sensitive to bulk fibrillization. After an incubation time
between 8 and 12 h, the MPEG and MBARE curves show decreas-
ing slopes that present a similar rate. Therefore, for long incu-
bation time, (over 8 and 12 h), the temporal evolution of the
refractive index change is in general related to the bulk of the
solution only, Dnb, where the fibrillization of the Ab(1-42) pep-
tide occurs, regardless of the surface functionalization. The sur-
face-loading process only results in a decrease of sensitivity,
still allowing estimating the time rate of Dnb.
2.3. Protofibrillar and Fibrillar Ab(1–42) Aggregation
We finally considered Ab(1-42) samples containing defined
populations of Ab species, including protofibrillar and fibrillar
forms of Ab(1-42), prepared as described in the Experimental
Section. The purpose of these measurements was to try identi-
fying the different aggregation states with the sensograms ob-
tained along the amyloid pathway of Ab(1-42) samples. Protofi-
bril samples are heterogeneous prefibrillar aggregates of differ-
ent morphologies and sizes,[9] reported to be generally unable
to assemble into fibrils in the absence of the Ab(1-42) mono-
mer,[12] and showing low induced fluorescence response upon
binding ThT. The mature aggregates, the fibrils, filamentous
aggregates presenting considerable b-sheet structure, strongly
bind ThT (see the Supporting Information, Figure S1). The re-
sulting profiles of protofibrils (PFBARE) and fibrils (FBARE), incubat-
ed at 37 8C in the BSW sensing cell with a bare multilayer, are
shown in Figure 2A, and compared to the profile of the mono-
meric peptide incubation (MBARE). Monomeric, protofibrillar and
fibrillar forms of Ab(1-42) peptide present three distinct curves
for the evolution of the refractive index over time. Regardless
of the starting material used, the overall Dn decreases on the
long run. The variation of the refractive index of the incubated
protofibrils and fibrils is smoother with respect to the case of
monomeric species, during incubation at 37 8C. Previous stud-
ies[9,12b] suggest that, Ab(1-42) fibrils and, specially, purified pro-
tofibril species present a less pronounced tendency to further
assembly, being already embedded in an organized aggrega-
tion pattern. The TEM micrographs reveal a slow evolution of
the Ab(1-42) protofibril during a 24-hour period of incubation,
as shown in micrographs a, a1 and b, b1 in Figure 2B.
Concerning the surface loading effect, we do not report an
appreciable Dn increase when mature fibrils, identified by TEM
imaging (Figure 2B, micrograph c), are incubated in the BSW
sensing cell. This evidence allows inferring that surface adsorp-
tion of mature fibrils can be safely neglected in this specific
case. Since fibrils were obtained incubating a purified mono-
meric Ab(1-42) sample at 37 8C for 48 h, the incubation of
these mature aggregates can be even considered as a continu-
ation of the measurement of the Ab(1-42) monomer incuba-
tion, after 48 h, unaffected by any significant peptide interac-
tion with the multilayer. More interestingly, BSW monitoring of
the protofibrillar Ab(1-42) form shows no substantial surface
adsorption. This observation is indicated by a minute increase
of the Dn value during the first period of the incubation, as
compared to the Dn of the MBARE profile. The observed increase
stays small especially if one takes into account that a four
times smaller concentration of monomer was used in the ex-
periment.
Accordingly, the surface adsorption mechanism onto the un-
functionalised multilayer is found to be a process associated
with and depending on the Ab(1-42) peptide in a specific ag-
gregation form. Protofibrils seem to be less prone to be ad-
sorbed onto the surface. The species that are strongly ad-
sorbed onto the multilayer oxinitride surface have to be in
a precise pre-fibrillar conformation, with a lower molecular
weight than the average weight attributed to protofibrils.
3. Conclusions
The present work describes how a photonic crystal-based opti-
cal platform can be applied to monitor the Ab(1-42) peptide
aggregation during the early events of the fibrillization process
that leads to Alzheimer’s disease. By sensing the refractive
index change of the peptide solution, this approach provides
unprecedented information covering the transition period
from a homogenous dispersion, the monomer solution, to
a heterogeneous suspension containing fibrillar amyloids. The
presented photonic crystal-based approach provides relevant
information on the aggregation of Ab(1-42) peptides during
the nucleation process, the silent lag phase, where other classi-
cal amyloid detection methods are limited by their sensitivity.
As reported in the literature,[13] the Ab(1-42) peptide under-
goes major morphological changes during the aggregation
process. The variation of the Ab(1-42) secondary structure has
been extensively demonstrated,[14] especially in the transition
from the monomeric form to the soluble oligomeric forms and
these changes vary the water-exposed surface of the pep-
tide.[15] We suggest that the Ab(1-42) peptide desorption from
the sensing surface, confirmed by the PEG-coating passivation
experiment, should be caused by a variation in the secondary
structure of the species initially adsorbed onto the multilayer
surface. In the pathway from the oligomeric forms to the
mature fibrils the structures become more compact and
expose a different pattern that has less affinity to the surface.
The TEM micrographs in Figure 1B are in good agreement
with this hypothesis, showing the formation of oligomeric pro-
tofibrils from lower to higher molecular weight, in correspond-
ence with the establishment of the maximum amplitude of the
Dn signal for the monomeric profile MBARE. The presented re-
sults support the hypothesis that the interaction with the un-
functionalized bare surface may be determined by a specific
early molecular structure variation. An analogous event has
been reported by Yagi et al. ,[16] whose work suggests the for-
mation of oligomeric Ab seeds attached to a quartz surface.
The results obtained by monitoring the Ab(1-42) aggrega-
tion in the presence of a passivated surface allowed demon-
strating that the interaction with the silicon oxinitride multilay-
er surface is not fundamentally modifying the mechanism of
the aggregation. Without PEG, for long incubation time, the
mass-loading mechanism has definitely reached a stationary
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condition, resulting in the formation of an overlayer of Ab(1-
42) peptide steadily adsorbed on the surface. The presence of
such an overlayer produces a shielding effect leading to a gen-
eral overestimation of the solution refractive index. With PEG,
almost no overlayer is formed on the surface and the BSW res-
onance position can be more directly related to the refractive
index of the solution.
Despite the technical limitations imposed by the prototype
system, our approach reveals a high potential that might over-
come some of the limitations in other techniques.[17] The pre-
sented photonic crystal-based approach is a novel promising
candidate for direct, label-free and real-time monitoring of the
Ab transitions during oligomerization at early stages. In per-
spective, this innovative amyloid-sensing strategy can be ex-
ploited to screen for molecular factors that influence the oligo-
merization process. Furthermore, the photonic crystal-based
sensing can serve as a direct screening tool for new potential
inhibitors of Ab(1-42) toxic oligomers and early nucleation
events.
Experimental Section
Ab(1–42) Monomer, Protofibril and Fibril Preparation and
Characterization
The Ab(1-42) amyloid peptide for all the experiments was provided
by the group of Hilal Lashuel, Laboratory of Molecular and Chemi-
cal Biology of Neurodegeneration, EPFL (Lausanne, Switzerland)
and synthesized and purified as TFA salts by Elliott, WM Keck Facili-
ty, Yale University (New Haven, USA) as described in the litera-
ture.[18]
The preparation of Ab(1-42) monomer was performed by dissolv-
ing the peptide in 6m guanidine HCl and purifying it via size exclu-
sion chromatography (SEC). For this purpose, the column Superdex
75 10/300 GL (GE Healthcare, Uppsala, Sweden) was used. Ab(1-42)
protofibril (PF) was obtained by dissolving the peptide in 100%
DMSO and diluting the solution in ultrapure H2O, then purifying
the obtained solution via SEC, using the chromatographic column
described above.[9] The concentration of the samples was deter-
mined by UV/Vis spectroscopy, using a molar extinction coefficient
of 1490m1 cm1 at 280 nm. Buffers and solvents for peptide prep-
aration and SEC were purchased from SIGMA Aldrich and Fluka AG
(Buchs, Switzerland). The preparation of Ab(1-42) fibril (F) was per-
formed by incubating the monomer sample at 37 8C for 48 h. The
procedure for Ab(1-42) monomer, PF and F production was carried
out according to the protocol developed by Jan et al.[9]
TEM imaging was performed depositing 2 mL of peptide samples
on Formvar/carbon-coated TEM grids negative stained by means
of uranyl acetate 2%.[9] The preparation of the TEM grids was car-
ried out soon after sample preparation and then after different
time lapses (from time 0 to 48 h for the monomer, at time 0 and
24 h for the protofibril, and at time 0 for the fibril) during peptide
incubation at 37 8C. Both the grids and the stain were purchased
from Electron Microscopy Sciences (Hatfield, USA). Micrographs
were acquired on a Philips CM200 Transmission Electron Micro-
scope.
Ab(1-42) Aggregation Analysis with an Approach Based on
Bloch Surface Waves
Periodic stacks of dielectric materials (known as photonic crystals)
with different refractive index constants can sustain optical surface
modes[19] with either transverse electric (TE) or transverse magnetic
(TM) polarization. Such modes are called Bloch surface waves
(BSWs) and have a significant amount of their overall power con-
fined close to the truncation interface of the photonic crystal.[20] In
our experiment, the photonic structure is a multilayer made of al-
ternating layers of silicon oxinitride and silica, as previously report-
ed.[21] The multilayer is deposited on a glass substrate with an
Oxford Plasmalab 80+ PECVD machine. The top layer, which is in
contact with the sensed media, is silicon oxinitride.
The experimental apparatus developed in-house consists of
a prism-based goniometric setup, as depicted in Figure 3A, where-
in a proper silicon-based multilayer is used as a photonic structure
sustaining BSWs. A TM-polarized laser (wavelength 632.8 nm)
source is first collimated, then focused (lens focal length 40 mm,
diameter 165 mm) and expanded on the multilayer through the
side facet of a prism. The angle of incidence of the beam on the
prism can be varied in a controlled way. The glass substrate host-
ing the multilayer is optically contacted to the prism by means of
Figure 3. A) Schematic top-view of the optical setup. A He–Ne laser (1) is used to illuminate the photonic crystal contacted to a prism (4) and the beam is
conditioned by using an objective (2) and two subsequent lenses (3) in order to obtain the divergent incident beam whose optical rays are incident on the
multilayer at different angles. The light is then reflected by the multilayer (5) towards the CMOS camera. B) Lateral enlargement of the sensing chamber. The
microfluidic cell is positioned vertically. The laser beam generates the BSW probing the protein solution via an evanescent tail of its associated electromagnet-
ic field distribution. As for SPR, the coupling is observed as an intensity dip in the reflected angular distribution (represented in dark). Any variation in the re-
fractive index of the liquid is resulting in a shift of the reflection minimum (in pixel).
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an index-matching oil, according to the attenuated total reflection
configuration. As the laser impinges on the multilayer at the specif-
ic BSW resonant angle, part of the laser power is transferred to the
BSW mode, resulting in an evanescent field extended in the exter-
nal (aqueous) medium for a distance of about 0.5 mm. As a result,
the corresponding reflected spot shows a decrease of light intensi-
ty (resonance dip). The reflected spot containing the BSW reso-
nance dip is leaving the prism with a given angular divergence,
and is imaged on a linear camera. The position of the dip on the
linear camera is indicative of the angular position of the BSW reso-
nance dip and hence of the refractive index as sensed by the BSW.
The sensing approach is similar to the well-known SPR scheme.[22]
The truncation interface of the photonic multilayer is sealed to
a fluidic cell, in which a thermocouple and a Peltier element in
closed feedback loop can maintain a constant temperature.
In the present work, we exploit BSWs to locally probe the refractive
index variations (Dn) of a solution wherein the Ab(1-42) peptide is
initially injected in a monomeric form and is progressively aggre-
gating to form fibrils (Figure 3B). During this process, the Ab(1-42)
peptide tends to precipitate away from the multilayered surface,
since the sensing chamber is vertically positioned. As refractive
index perturbations occur within the fluidic cell, the position of the
BSW dip shifts. The angular position of the dip moves toward
larger output angles as the refractive index increases (see Fig-
ure 3B).
The incubation of samples is performed at 37 8C (uncertainty
0.1 8C) via the use of a Peltier thermoelectric thermostat system
connected to a temperature controller Lightwave ILX (Bozeman,
USA). The data acquisition of the BSW dip resonance position is
started 1 min after the injection of the sample solution in the cell,
in order to stabilize the temperature of the fluidic cell. The laser
beam reflected from the multilayer is directed to the detector,
a 1.3 MP Monochrome 8-bit CMOS Camera purchased from Might-
ex (Toronto, Canada), which allows monitoring the angular shift of
the resonance conditions through the camera pixels. The response
will thereforebe reported in numbers of pixels (Figure 3B).
For the results presented in this work, it is important to stress that
the zero value in pixel shift corresponds to the BSW resonance po-
sition at the beginning of the measurement, and not to the signal
of the reference buffer solution (10 mm Tris HCl). To guarantee
identical initial experimental conditions, a new multilayer was used
for each different measurement. The optical response is tested
before each measurement in order to assess the BSW robustness.
In order to calibrate the response of the BSW dip shift upon refrac-
tive index perturbations in the solution,[23] control experiments
were performed using solutions with different known refractive in-
dices. For our experimental refractive index range, the result is
a linear relationship between the observed shift and the refractive
index of the solution as predicted by known formulas.[8b] If we esti-
mate the sensitivity as n8 pixelRIU1 (refractive index units), the ob-
tained experimental sensitivity is Spixel=12778 pixelsRIU
1. The ex-
perimentally observed resolution is Dn=1.5104 RIU, which is
sufficient for our measurements.
Polyethylene Glycol Self-Assembled Monolayer Coating
All the reagents and solvents were purchased from SIGMA Aldrich
and Fluka AG (Buchs, Switzerland), and Honeywell (Seelze, Germa-
ny). Methoxy polyethylene glycol amine 750 was purchased from
SIGMA Aldrich. The chemical modification of the multilayer surface
was performed with a method described elsewhere.[24] Methoxy
polyethylene glycol amine 750, an a- and w-substituted PEG deri-
vate, was linked to the silicon oxinitride top layer of the multilayer.
The silicon oxinitride surface was treated with piranha solution (3:1
H2SO4:H2O2) that generates silanols functions Si-OH able to react
with amino-propyl-triethoxy-silanes (APTES). The free amine groups
of APTES react with an N-hydroxysuccinimide (NHS) ester function
of the acetal protected linker. The acetal protecting group of the
linker is subsequently deprotected liberating the aldehyde. The
amino end-group of the modified PEG molecule is reductively cou-
pled to the carbonyl group of the linker. The homogeneity of the
resulting PEG coating was confirmed using in-dark-field optical mi-
croscopy.
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